Cargando…
The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report
Anti-vascular endothelial growth factor (anti-VEGF) therapy used as adjunctive to glaucoma filtration surgery may help filtering bleb survival because vascular endothelial growth factor has an important role in the angiogenesis of new vessels and in the fibrogenesis, which lead to scar formation and...
Autores principales: | Popescu, V, Leasu, C, Stana, D, Alexandrescu, C, Dumitrescu, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397507/ https://www.ncbi.nlm.nih.gov/pubmed/25914750 |
Ejemplares similares
-
The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
por: Stana, D, et al.
Publicado: (2014) -
Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
por: Choi, Jin Young, et al.
Publicado: (2010) -
Clinical use of Bevacizumab in treating refractory glaucoma
por: Popescu, V, et al.
Publicado: (2015) -
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
por: Britton, Anna Krystyna, et al.
Publicado: (2020) -
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011)